| CYRA a fast acting PPI for control of Acid peptic disorders. |
Composition:
Rabeprazole Sodium 20 mg Enteric Coated Tablets.
( In Beta Cyclodextrin) |
| Mechanism of action |
Rabeprazole belongs to class of proton pump inhibitors which suppress gastric acid secretion by inhibiting the gastric H+ / K+ ATPase at the secretory surface of the gastric parietal cells. It does not have anti cholinergic or anti histaminic properties. |
| Indications |
Acid peptic disorders, Peptic ulcer disease ,GERD |
| Side effects |
Adverse events with Rabeprazole are mild to moderate in intensity and include malaise, diarrhoea, nausea, skin eruptions, headache and dizziness.
|
Precautions &
contraindications |
Hypersensitivity to Rabeprazole, substituted benzimidazoles or any of components of its pharmaceutical forms.
|
| Sales Pack |
CYRA : Pack of 100 tabs/ box (10 x 10) |
